首页> 外文OA文献 >A NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFECTION IN DYSPEPTIC PATIENTS

【2h】

A NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFECTION IN DYSPEPTIC PATIENTS

机译：一种新型三种药物RIGEMEN（Moxifloxacin-Omeprazole - 尼硝唑类）与传统的三重疗法进行治疗和消除幼稚和抗性H.Pylori感染的传统三重疗法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mahmoud Mostafa Abd El-Hamid; Ahmed Abd El-Aleem Ahmed; Mohammed Zakaria Abu Amer;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates [J] . RakiciH., Akdo?anR.A., BedirR., Journal of digestive diseases . 2014,第9期

机译：标准三联疗法，序贯疗法和基于莫西沙星的三联疗法对幽门螺杆菌感染的比较：患者的依从性和细菌清除率
2. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. [J] . Basu PP, Rayapudi K, Pacana T, The American Journal of Gastroenterology . 2011,第11期

机译：比较左氧氟沙星，奥美拉唑，硝唑尼特和强力霉素与三联疗法根除幽门螺杆菌的随机研究。
3. Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study. [J] . Mantzaris GJ, Petraki K, Archavlis E, European journal of gastroenterology and hepatology . 2002,第11期

机译：奥美拉唑三联疗法与奥美拉唑四联疗法治疗十二指肠溃疡和根除幽门螺杆菌感染：24个月的随访研究。
4. Formulation and in-vitro characterization of an intra-gastric drug delivery systemcontaining Ofloxacin and Ornidazole for treatment of H.pylori infection [C] . Babbar.M., Khan. I. Z., Talegaonkar, Annual meeting exposition of the Controlled Release Society . 2005

机译：含氧氟沙星和奥硝唑的胃内给药系统用于幽门螺杆菌感染的制剂和体外表征
5. A Retrospective Analysis of Patients with AF and HF Undergoing Treatment with Drug Therapy Vs Catheter Ablation: Which Was Better? [D] . Maffre, Jennifer. 2018

机译：患有药物治疗治疗的AF和HF患者的回顾性分析VS导管消融：哪个更好？
6. A Randomized Study Comparing Levofloxacin Omeprazole Nitazoxanide and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori [O] . P Patrick Basu, Krishna Rayapudi, Tommy Pacana, -1

机译：比较左氧氟沙星奥美拉唑硝唑尼特和强力霉素与三联疗法根除幽门螺杆菌的随机对照研究
7. A Novel Three Drug Rigemen (Moxifloxacin –Omeprazole - Nitazoxanide) in Comparison to Traditional Triple Therapy for Treatment and Eradication of Naïve and Resistant H. Pylori Infection in Dyspeptic Patients [O] . Ahmed Abd El Aleem Ahmed, Mohammed Zakaria Abu Amer, Mahmoud Mostafa Abd El Hamid 2019

机译：一种新型三种药物RIGEMEN（Moxifloxacin-Omeprazole - 尼硝唑烷）与传统的三重治疗进行治疗和消除Naïve和抗性H.幽门螺杆菌感染的传统三重疗法相比
8. Development of Diazaquinomycin Class Antibiotics for the Treatment of Drug-Resistant TB Infections. [R] . Franzblau, S., Klein, L. 2016

机译：Diazaquinomycin类抗生素治疗耐药结核病的研究进展。

A NOVEL THREE DRUG RIGEMEN (MOXIFLOXACIN –OMEPRAZOLE - NITAZOXANIDE) IN COMPARISON TO TRADITIONAL TRIPLE THERAPY FOR TREATMENT AND ERADICATION OF NAÏVE AND RESISTANT H.PYLORI INFECTION IN DYSPEPTIC PATIENTS

著录项

引文网络

相似文献

相关主题

期刊订阅